Improvement of myotonic conditions caused by the following diseases: Neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain.
Spastic paralysis caused by the following diseases: Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, post-surgical sequelae, sequelae of trauma, amyotrophic lateral sclerosis, infantile cerebral palsy, spinocerebellar degeneration, spinal vascular disorders, subacute myelo-optico neuropathy and other encephalomyelopathies

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: M
Dosage form: Film coated tablet
Packaging: 10's x 6
Therapeutic area: Active pharmaceutical ingredient: